VEXAS Syndrome: An Emerging Autoinflammatory Paraneoplastic Disorder

Area of Science:

• Genetics and Immunology
• Somatic Gene Disorders
• Autoinflammatory Diseases

Background:

• VEXAS syndrome is a newly identified autoinflammatory condition.
• It is characterized by somatic mutations in the UBA1 gene.
• The syndrome primarily impacts older males, with rare occurrences in females with X-chromosome mosaicism.

Purpose of the Study:

• To review the key features of VEXAS syndrome.
• To highlight diagnostic challenges and current therapeutic strategies.
• To emphasize the need for further research into VEXAS syndrome.

Main Methods:

• Literature review of VEXAS syndrome cases.
• Analysis of clinical and genetic findings.
• Synthesis of current treatment modalities and outcomes.

Main Results:

• VEXAS syndrome presents with significant dermatologic manifestations in up to 90% of patients.
• Hallmark clinical and laboratory findings include macrocytic anemia and myeloid vacuolization.
• Diagnostic challenges arise from overlapping symptoms with other hematologic and autoimmune disorders.

Conclusions:

• Understanding VEXAS syndrome's epidemiology and pathophysiology is vital for accurate diagnosis.
• Further research is needed to establish long-term treatment efficacy.
• Improved diagnostic strategies and therapeutic approaches are essential for better patient outcomes.